Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lippman

Showing results (331-340 of 551) with videos related to

Pageof 56
Sort By:
Carcinogenesis|July 15, 2010
Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinomaJianming Wang, Scott M Lippman, J Jack Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skinJ L Clifford, D G Menter, X Yang, et al.
Head & Neck|January 1, 1994
Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experienceM H Shirinian, R S Weber, S M Lippman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancerM H Huber, S M Lippman, S E Benner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphomaD J Slymen, T P Miller, S M Lippman, et al.
Journal of Thoracic Disease|August 14, 2025
Curative intent therapy of stage I-III non-small cell lung cancer: a patient-centered precision approach to assess, measure, and interpret benefits and harmsDuc M Ha, Melissa L New, Simran K Randhawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 1, 2010
Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in miceJörg J Jacoby, Baruch Erez, Maria V Korshunova, et al.
Oral Oncology|January 23, 2017
Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinomaAswini R Krishnan, Avinaash Korrapati, Angela E Zou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancyHidetoshi Kawaguchi, Adel K El-Naggar, Vali Papadimitrakopoulou, et al.
Iscience|August 16, 2024
Molecular Tumor Board for Unicorns: Outcomes for rare and ultra-rare cancers using an N-of-One personalized treatment strategyBryan H Louie, Shumei Kato, Jordan S Lim, et al.
Pageof 56

Showing results (331-340 of 551) with videos related to

Sort By:
Pageof 56
Carcinogenesis|July 15, 2010
Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinomaJianming Wang, Scott M Lippman, J Jack Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skinJ L Clifford, D G Menter, X Yang, et al.
Head & Neck|January 1, 1994
Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experienceM H Shirinian, R S Weber, S M Lippman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancerM H Huber, S M Lippman, S E Benner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphomaD J Slymen, T P Miller, S M Lippman, et al.
Journal of Thoracic Disease|August 14, 2025
Curative intent therapy of stage I-III non-small cell lung cancer: a patient-centered precision approach to assess, measure, and interpret benefits and harmsDuc M Ha, Melissa L New, Simran K Randhawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 1, 2010
Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in miceJörg J Jacoby, Baruch Erez, Maria V Korshunova, et al.
Oral Oncology|January 23, 2017
Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinomaAswini R Krishnan, Avinaash Korrapati, Angela E Zou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancyHidetoshi Kawaguchi, Adel K El-Naggar, Vali Papadimitrakopoulou, et al.
Iscience|August 16, 2024
Molecular Tumor Board for Unicorns: Outcomes for rare and ultra-rare cancers using an N-of-One personalized treatment strategyBryan H Louie, Shumei Kato, Jordan S Lim, et al.
Pageof 56